Corestreet Logo

Nabriva Therapeutics AG (NBRV) Insider Trading

Total insider buys:
  • $1,091,510.38
Total insider sells:
  • $4,853,383.03
Most recent insider trade:
  • Aug. 1, 2022
Most active insider trader:
  • Hbm Healthcare Investments (Ca
Trader NameDateTitleAmountPriceTypeTotal Value
Aug. 1, 2022Director8,496$0.17Sell$1,444.32
Dec. 28, 2021CEO100,000$0.57Buy$57,000.00
Dec. 27, 2021General Counsel7,000$0.59Buy$4,130.00
Sept. 14, 2021CEO50,000$1.13Buy$56,500.00
Aug. 2, 2021Director777$1.20Sell$932.40
Aug. 20, 2020Director11,064$0.65Sell$7,191.60
Aug. 30, 2019Director10,177$2.03Buy$20,659.31
Aug. 27, 2019CEO50,000$1.79Buy$89,500.00
Aug. 22, 2019Insider4,800$2.04Buy$9,792.00
Aug. 21, 2019CFO3,390$2.08Sell$7,051.20
Aug. 21, 2019COO8,206$2.08Sell$17,068.48
Aug. 21, 2019Director10,177$2.07Sell$21,066.39
Dec. 24, 2018Director53,000$1.31Buy$69,430.00
July 31, 2018Director36,000$2.75Buy$99,000.00
June 22, 2018Insider5,500$3.73Buy$20,515.00
June 22, 2018CEO5,000$3.72Buy$18,600.00
May 23, 2018CFO2,000$4.57Buy$9,140.00
May 23, 2018General Counsel10,000$4.48Buy$44,800.00
May 23, 2018Director8,000$4.59Buy$36,720.00
May 23, 2018Insider2,160$4.60Buy$9,936.00
Nov. 29, 2017Insider1,569$6.29Buy$9,869.01
Sept. 22, 2017CEO2,588$8.35Buy$21,609.80
Sept. 22, 2017CFO2,000$8.21Buy$16,420.00
Sept. 18, 2017Major Shareholder52,631$9.46Buy$497,889.26
Sept. 14, 2017Major Shareholder36,608$8.56Sell$313,364.48
Aug. 31, 2017Major Shareholder639$9.50Sell$6,070.50
Aug. 8, 2017Major Shareholder19,803$10.50Sell$207,931.50
Aug. 7, 2017Major Shareholder17,790$10.50Sell$186,795.00
July 28, 2017Major Shareholder6,585$10.51Sell$69,208.35
July 24, 2017Major Shareholder160$10.50Sell$1,680.00
July 20, 2017Major Shareholder44,231$10.50Sell$464,425.50
July 18, 2017Major Shareholder69,854$10.51Sell$734,165.54
July 13, 2017Major Shareholder57,175$10.53Sell$602,052.75
July 7, 2017Major Shareholder2,695$10.52Sell$28,351.40
July 3, 2017Major Shareholder13,127$10.94Sell$143,609.38
June 30, 2017Major Shareholder1,775$10.94Sell$19,418.50
June 29, 2017Major Shareholder8,558$10.96Sell$93,795.68
June 19, 2017Director170$93.18Sell$15,840.60
May 30, 2017Director210$101.26Sell$21,264.60
May 25, 2017Director325$100.56Sell$32,682.00
May 16, 2017Director200$102.44Sell$20,488.00
May 15, 2017Director50$101.50Sell$5,075.00
April 28, 2017Major Shareholder15,939$11.02Sell$175,647.78
April 21, 2017Major Shareholder2,622$11.04Sell$28,946.88
April 20, 2017Major Shareholder23,932$11.11Sell$265,884.52
April 13, 2017Major Shareholder32,831$11.24Sell$369,020.44
April 10, 2017Major Shareholder90,594$10.96Sell$992,910.24
First«1 of 1»Last

  • Insiders are both buying and selling Nabriva Therapeutics AG stock.

  • The insider traders at Nabriva Therapeutics AG are: Hbm Healthcare Investments (Ca, George Harrison Talbot, Colin Md Broom, Gary Sender, Francesco Maria Lavino, Theodore R Schroeder, Charles A Rowland Jr, Steven P Gelone, Theodore R. Schroeder, Vivo Capital Viii, Llc, Daniel D Burgess, J. Christopher Naftzger, Jennifer Schranz, Robert Crotty, Stephen W Webster, and Stephen W. Webster

  • The most active insider trader at Nabriva Therapeutics AG is Hbm Healthcare Investments (Ca with 18 trades.

  • Hbm Healthcare Investments (Ca has sold the most Nabriva Therapeutics AG stock with a total value of $5,016,642.92.

  • Vivo Capital Viii, Llc has bought the most Nabriva Therapeutics AG stock with a total value of $995,778.52.

  • The most recent insider trade for Nabriva Therapeutics AG was on Aug. 1, 2022.

  • The single biggest insider buy for Nabriva Therapeutics AG was from Vivo Capital Viii, Llc with a total value of $497,889.26 on Sept. 18, 2017.

  • The single biggest insider sell for Nabriva Therapeutics AG was from Hbm Healthcare Investments (Ca with a total value of $992,910.24 on April 10, 2017.